1. Home
  2. SCNX vs UBX Comparison

SCNX vs UBX Comparison

Compare SCNX & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCNX
  • UBX
  • Stock Information
  • Founded
  • SCNX 2010
  • UBX 2009
  • Country
  • SCNX United States
  • UBX United States
  • Employees
  • SCNX N/A
  • UBX N/A
  • Industry
  • SCNX Other Pharmaceuticals
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SCNX Health Care
  • UBX Health Care
  • Exchange
  • SCNX Nasdaq
  • UBX Nasdaq
  • Market Cap
  • SCNX 33.6M
  • UBX 36.9M
  • IPO Year
  • SCNX 2020
  • UBX 2018
  • Fundamental
  • Price
  • SCNX $3.15
  • UBX $2.19
  • Analyst Decision
  • SCNX
  • UBX Strong Buy
  • Analyst Count
  • SCNX 0
  • UBX 2
  • Target Price
  • SCNX N/A
  • UBX $7.00
  • AVG Volume (30 Days)
  • SCNX 10.8K
  • UBX 333.6K
  • Earning Date
  • SCNX 02-25-2025
  • UBX 11-04-2024
  • Dividend Yield
  • SCNX N/A
  • UBX N/A
  • EPS Growth
  • SCNX N/A
  • UBX N/A
  • EPS
  • SCNX 3.55
  • UBX N/A
  • Revenue
  • SCNX N/A
  • UBX N/A
  • Revenue This Year
  • SCNX $1,085.75
  • UBX N/A
  • Revenue Next Year
  • SCNX N/A
  • UBX $33.62
  • P/E Ratio
  • SCNX $1.37
  • UBX N/A
  • Revenue Growth
  • SCNX 166.67
  • UBX N/A
  • 52 Week Low
  • SCNX $3.01
  • UBX $0.94
  • 52 Week High
  • SCNX $44.56
  • UBX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • SCNX N/A
  • UBX 58.41
  • Support Level
  • SCNX N/A
  • UBX $1.81
  • Resistance Level
  • SCNX N/A
  • UBX $2.39
  • Average True Range (ATR)
  • SCNX 0.00
  • UBX 0.24
  • MACD
  • SCNX 0.00
  • UBX -0.05
  • Stochastic Oscillator
  • SCNX 0.00
  • UBX 59.38

About SCNX Scienture Holdings Inc. Common Stock

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: